Targeting MET kinase with the small-molecule inhibitor amuvatinib induces cytotoxicity in primary myeloma cells and cell lines
Cornel J. Phillip(The University of Texas Health Science Center at Houston), Varsha Gandhi(The University of Texas MD Anderson Cancer Center)
Cited by 22
Related Papers
Ibrutinib and Venetoclax for First-Line Treatment of CLL
|New England Journal of Medicine|2019|502
Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia
|Blood|2011|161
AT-101 induces apoptosis in CLL B cells and overcomes stromal cell–mediated Mcl-1 induction and drug resistance
|Blood|2008|147
B-cell Receptor Signaling Regulates Metabolism in Chronic Lymphocytic Leukemia
|Molecular Cancer Research|2017|50